Novo Nordisk A/S NOV-DE:XETRA
*Data is delayed | Exchange | EUR
Last | 5:35 PM CEST
36.52
-0.64 (-1.72%)
-0.64 (-1.72%)Volume
157,170
52 week range
30.24 - 71.53
- Open37.48
- Day High37.60
- Day Low36.32
- Prev Close37.16
- 52 Week High71.53
- 52 Week High Date06/13/25
- 52 Week Low30.24
- 52 Week Low Date03/27/26
Latest On Novo Nordisk A/S
- Cramer’s Mad Dash: Eli Lilly
CNBC.com
Key Stats
- Market Cap-
- Shares Out-
- 10 Day Average Volume-
- Dividend1.57
- Dividend Yield4.29%
- Beta-
Latest On Novo Nordisk A/S
- Cramer’s Mad Dash: Eli LillyCNBC.com
KEY STATS
- Open37.48
- Day High37.60
- Day Low36.32
- Prev Close37.16
- 52 Week High71.53
- 52 Week High Date06/13/25
- 52 Week Low30.24
- 52 Week Low Date03/27/26
- Market Cap-
- Shares Out-
- 10 Day Average Volume-
- Dividend1.57
- Dividend Yield4.29%
- Beta-
RATIOS/PROFITABILITY
- EPS (TTM)3.67
- P/E (TTM)9.94
- Fwd P/E (NTM)-
- EBITDA (TTM)-
- ROE (TTM)-
- Revenue (TTM)-
- Gross Margin (TTM)-
- Net Margin (TTM)-
- Debt To Equity (MRQ)-
EVENTS
- Earnings Date-
- Ex Div Date03/27/2026
- Div Amount7.95
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MORENovo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral...
Lars Rebien Soerensen
Non-Executive Chairman of the Board
Maziar Doustdar
President, Chief Executive Officer
Karsten Munk Knudsen
Chief Financial Officer, Executive Vice President
Ludovic Helfgott
Executive Vice President - Product and Portfolio Strategy
Emil Larsen
Executive Vice President - International Operations
Address
Novo Alle 1
Bagsvaerd
2880
Denmark